The Recent Medicinal Chemistry Development of Jak2 Tyrosine Kinase Small Molecule Inhibitors
Keywords: 4-tert-butyl sulfonamide; 5-bromoaminoindazole; G6; JAK2; Jak2-V617F mutation; STILBENES; aminoindazoles; azaindoles; benzoxazoles; cytokines; deazapurines; electronegativity; fluorine; hydroxyls; medicinal chemistry; myeloproliferative neoplasms (MPNs); phenolic hydroxide; pyrazines; pyrazolo nicotinonitrile; pyrimidines; quinoxalines; small molecule inhibitors; stilbenes; structure activity relationship (SAR); structure activity relationships; trifluoromethyl groups; tyrphostin AG490
Document Type: Research Article
Publication date: 2010-12-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.